Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

Sickle Cell Disease

Treatments and Services

BMC offers all treatments and therapies for sickle cell disease, including:

  • Gene therapies: Boston Medical Center is the only hospital in New England to offer transformative gene therapy to eligible adults with sickle cell disease. We offer both FDA-approved gene therapies for sickle cell disease, Casgevy and Lyfegenia.
  • Hydroxyurea
  • L-glutamine
  • Voxelotor
  • Crizanlizumab
  • Blood transfusions
  • Pain medications
  • Bone marrow transplant